博拓生物：全资子公司博肽智投 战略入股浙大脑机接口成果转化项目

Group 1 - The core viewpoint of the article highlights the successful completion of China's first closed-loop spinal cord nerve interface implantation surgery, which has garnered significant attention [1] - Botao Bio announced on May 20 that its wholly-owned subsidiary, Botai Zhito, has invested in Qingshi Yongjun and acquired a 5% equity stake [1] - Qingshi Yongjun was founded by the invasive brain-computer interface team from Zhejiang University and is the first technology transfer company of the South Lake Brain-Machine Cross-Research Institute [1]